allosteric modulator
An allosteric modulator binds a receptor at a side door rather than the main entrance, and from there it tunes how the receptor responds to its natural ligand — turning the volume up or down without necessarily playing the music itself. It works by binding an allosteric site, distinct from the orthosteric site where the endogenous agonist acts.
Modulators come in two main flavours. A positive allosteric modulator (PAM) increases the receptor's response to its natural ligand — boosting affinity, efficacy, or both — while a negative allosteric modulator (NAM) dampens it. Many modulators have little or no effect on their own; they only act when the natural ligand is present, so their influence is conditional on ongoing signaling.
This dependence on the endogenous signal is a key therapeutic appeal: an allosteric modulator can preserve the natural pattern and rhythm of signaling rather than overriding it, and because allosteric sites are less conserved than orthosteric ones, modulators can achieve subtype selectivity that direct agonists or antagonists struggle to reach. Benzodiazepines, which enhance GABA's action at the GABA-A receptor, are the classic example.
Benzodiazepines are positive allosteric modulators of the GABA-A receptor: they bind a site distinct from GABA's and increase the channel's response to GABA, enhancing inhibitory signaling.
An allosteric modulator tunes receptor activity from a site away from the natural ligand.
Many modulators show a 'ceiling' effect: because they amplify or damp the natural signal rather than acting alone, their effect saturates, which can give a wider safety margin than a direct agonist.